- $1.65bn
- $1.77bn
- $1.24bn
- 96
- 61
- 55
- 81
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,138 | 1,001 | 1,091 | 1,092 | 1,244 |
Cost of Revenue | |||||
Gross Profit | 462 | 408 | 439 | 421 | 528 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,066 | 937 | 1,008 | 1,005 | 1,105 |
Operating Profit | 71.8 | 63.7 | 82.4 | 87.2 | 139 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 54 | 41.1 | 74.1 | 79.5 | 124 |
Provision for Income Taxes | |||||
Net Income After Taxes | 45.9 | 33.7 | 64.9 | 66.3 | 110 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 45.8 | 33.7 | 64.9 | 66.3 | 110 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 45.8 | 33.7 | 64.9 | 66.3 | 110 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.84 | 2.03 | 3.82 | 3.56 | 5.98 |
Dividends per Share |